The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
MAPK/ERK Overrides the Apoptotic Signaling from Fas, TNF, and TRAIL Receptors
Open accessAbstract
The tumor necrosis factor (TNF), Fas, and TNF-related apoptosis-inducing ligand (TRAIL) receptors (R) are highly specific physiological mediators of apoptotic signaling. We observed earlier that a number of FasR-insensitive cell lines could redirect the proapoptotic signal to an anti-apoptotic ERK1/2 signal resulting in inhibition of caspase activation. Here we determine that similar mechanisms are operational in regulating the apoptotic signaling of other death receptors. Activation of the FasR, TNF-R1, and TRAIL-R, respectively, rapidly induced subsequent ERK1/2 activation, an event independent from caspase activity. Whereas inhibition of the death receptor-mediated ERK1/2 activation was sufficient to sensitize the cells to apoptotic signaling from FasR and TRAIL-R, cells were still protected from apoptotic TNF-R1 signaling. The latter seemed to be due to the strong activation of the anti-apoptotic factor NF-kappaB, which remained inactive in FasR or TRAIL-R signaling. However, when the cells were sensitized with cycloheximide, which is sufficient to sensitize the cells also to apoptosis by TNF-R1 stimulation, we noticed that adenovirus-mediated expression of constitutively active MKK1 could rescue the cells from apoptosis induced by the respective receptors by preventing caspase-8 activation. Taken together, our results show that ERK1/2 has a dominant protecting effect over apoptotic signaling from the death receptors. This protection, which is independent of newly synthesized proteins, acts in all cases by suppressing activation of the caspase effector machinery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics
Kerr, J. F. R., Wyllie, A. H., & Currie, A. R. (1972) · British Journal of Cancer · doi:10.1038/bjc.1972.33 · Cited by 15,725
Death Receptors: Signaling and Modulation
Ashkenazi, A., & Dixit, V. M. (1998) · Science · doi:10.1126/science.281.5381.1305 · Cited by 5,866
Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis
Xia, Z., Dickens, M., Raingeaud, J., Davis, R. J., & Greenberg, M. E. (1995) · Science · doi:10.1126/science.270.5240.1326 · Cited by 5,287
Caspases: the executioners of apoptosis
COHEN, G. M. (1997) · Biochemical Journal · doi:10.1042/bj3260001 · Cited by 4,719
Nicoletti, I., Migliorati, G., Pagliacci, M. C., Grignani, F., & Riccardi, C. (1991) · Journal of Immunological Methods · doi:10.1016/0022-1759(91)90198-o · Cited by 4,579
Nagata, S., & Golstein, P. (1995) · Science · doi:10.1126/science.7533326 · Cited by 3,979
Muzio, M., Chinnaiyan, A. M., Kischkel, F. C., O'Rourke, K., Shevchenko, A., Ni, J., Scaffidi, C., Bretz, J. D., Zhang, M., Gentz, R., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81266-0 · Cited by 3,046
Inhibition of death receptor signals by cellular FLIP
Irmler, M., Thome, M., Hahne, M., Schneider, P., Hofmann, K., Steiner, V., Bodmer, J.-L., Schröter, M., Burns, K., Mattmann, C., et al. (1997) · Nature · doi:10.1038/40657 · Cited by 2,563
Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.
Walczak, H., Miller, R. E., Ariail, K., Gliniak, B., Griffith, T. S., Kubin, M., Chin, W., Jones, J., Woodward, A., Le, T., et al. (1999) · Nature Medicine · doi:10.1038/5517 · Cited by 2,497
Boldin, M. P., Goncharov, T. M., Goltseve, Y. V., & Wallach, D. (1996) · Cell · doi:10.1016/s0092-8674(00)81265-9 · Cited by 2,292
Hsu, H., Shu, H.-B., Pan, M.-G., & Goeddel, D. V. (1996) · Cell · doi:10.1016/s0092-8674(00)80984-8 · Cited by 1,998
Liu, Z.-G., Hsu, H., Goeddel, D. V., & Karin, M. (1996) · Cell · doi:10.1016/s0092-8674(00)81375-6 · Cited by 1,937
The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death
Smith, C. A., Farrah, T., & Goodwin, R. G. (1994) · Cell · doi:10.1016/0092-8674(94)90372-7 · Cited by 1,887
Apoptosis control by death and decoy receptors
Ashkenazi, A., & Dixit, V. M. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)80034-9 · Cited by 1,288
Cyclin D1 Expression Is Regulated Positively by the p42/p44 and Negatively by the p38/HOG Pathway
Lavoie, J. N., L'Allemain, G., Brunet, A., Müller, R., & Pouysségur, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.34.20608 · Cited by 1,211
FLICE is activated by association with the CD95 death-inducing signaling complex (DISC)
Medema, J. P. (1997) · The EMBO Journal · doi:10.1093/emboj/16.10.2794 · Cited by 1,188
Apoptosis signaling by death receptors
Schulze‐Osthoff, K., Ferrari, D., Los, M., Wesselborg, S., & Peter, M. E. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2540439.x · Cited by 978
Apo2L/TRAIL-Dependent Recruitment of Endogenous FADD and Caspase-8 to Death Receptors 4 and 5
Kischkel, F. C., Lawrence, D. A., Chuntharapai, A., Schow, P., Kim, K. J., & Ashkenazi, A. (2000) · Immunity · doi:10.1016/s1074-7613(00)80212-5 · Cited by 975
Stanger, B. Z., Leder, P., Lee, T.-H., Kim, E., & Seed, B. (1995) · Cell · doi:10.1016/0092-8674(95)90072-1 · Cited by 971
Strand, S., Hofmann, W. J., Hug, H., Müller, M., Otto, G., Strand, D., Mariani, S. M., Stremmel, W., Krammer, P. H., & Galle, P. R. (1996) · Nature Medicine · doi:10.1038/nm1296-1361 · Cited by 897
FADD: Essential for Embryo Development and Signaling from Some, But Not All, Inducers of Apoptosis
Yeh, W.-C., Pompa, J. L. D. L., McCurrach, M. E., Shu, H.-B., Elia, A. J., Shahinian, A., Ng, M., Wakeham, A., Khoo, W., Mitchell, K., et al. (1998) · Science · doi:10.1126/science.279.5358.1954 · Cited by 893
The Role of c-FLIP in Modulation of CD95-induced Apoptosis
Scaffidi, C., Schmitz, I., Krammer, P. H., & Peter, M. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.3.1541 · Cited by 819
Sprick, M. R., Weigand, M. A., Rieser, E., Rauch, C. T., Juo, P., Blenis, J., Krammer, P. H., & Walczak, H. (2000) · Immunity · doi:10.1016/s1074-7613(00)80211-3 · Cited by 794
TRAIL Receptors 1 (DR4) and 2 (DR5) Signal FADD-Dependent Apoptosis and Activate NF-κB
Schneider, P., Thome, M., Burns, K., Bodmer, J.-L., Hofmann, K., Kataoka, T., Holler, N., & Tschopp, J. (1997) · Immunity · doi:10.1016/s1074-7613(00)80401-x · Cited by 696
FAP-1: A Protein Tyrosine Phosphatase That Associates with Fas
Sato, T., Irie, S., Kitada, S., & Reed, J. C. (1995) · Science · doi:10.1126/science.7536343 · Cited by 683
TRAIL receptor-2 signals apoptosis through FADD and caspase-8
Bodmer, J.-L., Holler, N., Reynard, S., Vinciguerra, P., Schneider, P., Juo, P., Blenis, J., & Tschopp, J. (2000) · Nature Cell Biology · doi:10.1038/35008667 · Cited by 649
Wang, J., Zheng, L., Lobito, A., Chan, F. K.-M., Dale, J., Sneller, M., Yao, X., Puck, J. M., Straus, S. E., & Lenardo, M. J. (1999) · Cell · doi:10.1016/s0092-8674(00)80605-4 · Cited by 640
Activation of Apoptosis Signal-Regulating Kinase 1 (ASK1) by the Adapter Protein Daxx
Chang, H. Y., Nishitoh, H., Yang, X., Ichijo, H., & Baltimore, D. (1998) · Science · doi:10.1126/science.281.5384.1860 · Cited by 593
Hetman, M., Kanning, K., Cavanaugh, J. E., & Xia, Z. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.32.22569 · Cited by 575
The caspase-8 inhibitor FLIP promotes activation of NF-κB and Erk signaling pathways
Kataoka, T., Budd, R. C., Holler, N., Thome, M., Martinon, F., Irmler, M., Burns, K., Hahne, M., Kennedy, N., Kovacsovics, M., et al. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00512-1 · Cited by 552
Nakano, H., Shindo, M., Sakon, S., Nishinaka, S., Mihara, M., Yagita, H., & Okumura, K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3537 · Cited by 517
Monocyte-mediated Tumoricidal Activity via the Tumor Necrosis Factor–related Cytokine, TRAIL
Griffith, T. S., Wiley, S. R., Kubin, M. Z., Sedger, L. M., Maliszewski, C. R., & Fanger, N. A. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.8.1343 · Cited by 476
Multiple signals converging on NF-κB
Mercurio, F., & Manning, A. M. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)80030-1 · Cited by 473
TRAIL: a molecule with multiple receptors and control mechanisms
Griffith, T. S., & Lynch, D. H. (1998) · Current Opinion in Immunology · doi:10.1016/s0952-7915(98)80224-0 · Cited by 453
FLICE Is Predominantly Expressed as Two Functionally Active Isoforms, Caspase-8/a and Caspase-8/b
Scaffidi, C., Medema, J. P., Krammer, P. H., & Peter, M. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.43.26953 · Cited by 390
Inhibition of TNF-induced apoptosis by NF-κB
Van Antwerp, D. J., Martin, S. J., Verma, I. M., & Green, D. R. (1998) · Trends in Cell Biology · doi:10.1016/s0962-8924(97)01215-4 · Cited by 367
Sequential protein kinase reactions controlling cell growth and differentiation
Johnson, G. L., & Vaillancourt, R. R. (1994) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(94)90141-4 · Cited by 335
Antitumor effect of locally produced CD95 ligand
Seino, K.-I., Kayagaki, N., Okumura, K., & Yagita, H. (1997) · Nature Medicine · doi:10.1038/nm0297-165 · Cited by 312
14-3-3 proteins block apoptosis and differentially regulate MAPK cascades
Xing, H. (2000) · The EMBO Journal · doi:10.1093/emboj/19.3.349 · Cited by 285
Sedger, L. M., Shows, D. M., Blanton, R. A., Peschon, J. J., Goodwin, R. G., Cosman, D. J., & Wiley, S. R. (1999) · PubMed · Cited by 270
Ahonen, M., Baker, A. H., & Kähäri, V. (1998) · PubMed · Cited by 266
Self-citationMitogen-activated protein kinase-mediated Fas apoptotic signaling pathway
Goillot, E., Raingeaud, J., Ranger, A., Tepper, R. I., Davis, R. J., Harlow, E., & Sanchez, I. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3302 · Cited by 263
TNF, immunity and inflammatory disease: lessons of the past decade.
Beutler, B. (1995) · PubMed · Cited by 253
Michaelson, J. S., Bader, D., Kuo, F., Kozak, C., & Leder, P. (1999) · Genes & Development · doi:10.1101/gad.13.15.1918 · Cited by 241
Sedger, L. M., Shows, D. M., Blanton, R. A., Peschon, J. J., Goodwin, R. G., Cosman, D., & Wiley, S. R. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.2.920 · Cited by 232
Nemoto, S., DiDonato, J. A., & Lin, A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.12.7336 · Cited by 224
Hu, W.-H., Johnson, H., & Shu, H.-B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.43.30603 · Cited by 219
Gardner, A. M., & Johnson, G. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.24.14560 · Cited by 215
Constitutive and enhanced expression from the CMV major IE promoter in a defective adenovirus vector
Wilkinson, G. W. G., & Akrigg, A. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.9.2233 · Cited by 214
Mitogen-activated Protein Kinase Pathway Is Involved in the Differentiation of Muscle Cells
Gredinger, E., Gerber, A. N., Tamir, Y., Tapscott, S. J., & Bengal, E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.17.10436 · Cited by 212
Activation of apoptosis by Apo-2 ligand is independent of FADD but blocked by CrmA
Marsters, S. A., Pitti, R. M., Donahue, C. J., Ruppert, S., Bauer, K. D., & Ashkenazi, A. (1996) · Current Biology · doi:10.1016/s0960-9822(09)00456-4 · Cited by 195
Holmstrom, T. H. (2000) · The EMBO Journal · doi:10.1093/emboj/19.20.5418 · Cited by 186
Wajant, H., Haas, E., Schwenzer, R., Mühlenbeck, F., Kreuz, S., Schubert, G., Grell, M., Smith, C., & Scheurich, P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000811200 · Cited by 181
Mühlenbeck, F., Schneider, P., Bodmer, J.-L., Schwenzer, R., Hauser, A., Schubert, G., Scheurich, P., Moosmayer, D., Tschopp, J., & Wajant, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000482200 · Cited by 153
Foschi, M., Chari, S., Dunn, M. J., & Sorokin, A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.21.6439 · Cited by 153
Mühlenbeck, F., Haas, E., Schwenzer, R., Schubert, G., Grell, M., Smith, C. W., Scheurich, P., & Wajant, H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.33091 · Cited by 143
Expression of c-erbB receptors, heregulin and oestrogen receptor in human breast cell lines
DeFazio, A., Chiew, Y.-E., Sini, R. L., Janes, P. W., & Sutherland, R. L. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20000815)87:4<473::aid-ijc3>3.0.co;2-1 · Cited by 137
The CD95 (APO-1/Fas) Receptor Activates NF- B Independently of Its Cytotoxic Function
Ponton, A., Clement, M., & Stamenkovic, I. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.15.8991 · Cited by 136
Fried, J., Perez, A. G., & Clarkson, B. (1978) · Journal of Histochemistry & Cytochemistry · doi:10.1177/26.11.82573 · Cited by 135
Yeh, J.-H., Hsu, S., Han, S., & Lai, M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.10.1795 · Cited by 128
Dupont‐Versteegden, E. E., Murphy, R. J. L., Houlé, J. D., Gurley, C. M., & Peterson, C. A. (1999) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1999.277.3.c589 · Cited by 127
Holmström, T. H., Tran, S. E. F., Johnson, V., Ahn, N. G., Chow, S. C., & Eriksson, J. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.5991 · Cited by 106
Self-citationSuppression of Fas/APO-1-Mediated Apoptosis by Mitogen-Activated Kinase Signaling
Holmström, T. H., Chow, S. C., Elo, I., Coffey, E. T., Orrenius, S., Sistonen, L., & Eriksson, J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.6.2626 · Cited by 106
Self-citationMandal, M., Maggirwar, S. B., Sharma, N., Kaufmann, S. H., Sun, S., & Kumar, R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.48.30354 · Cited by 104
Raf-1/MEK/MAPK Pathway Is Necessary for the G2/M Transition Induced by Nocodazole
Hayne, C. C., Tzivion, G., & Luo, Z. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002766200 · Cited by 98
MacFarlane, M., Cohen, G. M., & Dickens, M. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3480093 · Cited by 67
MEK1 Activation Rescues Jurkat T Cells from Fas-Induced Apoptosis
Wilson, D. J., Alessandrini, A., & Budd, R. C. (1999) · Cellular Immunology · doi:10.1006/cimm.1999.1486 · Cited by 58
Phosphorylation-Based Signaling in Fas Receptor-Mediated Apoptosis
Holmström, T. H., & Eriksson, J. (2000) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v20.i2.30 · Cited by 40
Self-citation
Cited by
Frisch, S. M., & Screaton, R. A. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00251-9 · Cited by 1,249
Apo2L/TRAIL and its death and decoy receptors
LeBlanc, H. N., & Ashkenazi, A. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401187 · Cited by 854
Life and death by death receptors
Guicciardi, M. E., & Gores, G. J. (2009) · The FASEB Journal · doi:10.1096/fj.08-111005 · Cited by 690
ERK1/2 MAP kinases in cell survival and apoptosis
Lu, Z., & Xu, S. (2006) · IUBMB Life · doi:10.1080/15216540600957438 · Cited by 648
Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy
Almasan, A., & Ashkenazi, A. (2003) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(03)00029-7 · Cited by 553
Metadata
- Authors
- Tran, S. E. F., Holmström, T. H., Ahonen, M., Kähäri, V.-M., & Eriksson, J. E.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2001-05
- Volume
- 276
- Issue
- 19
- Pages
- 16484-16490
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2042561434
- Cited by
- 330
- References
- 68
- FWCI
- 9.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.